Esophagitis dissecans superficialis (EDS) is a rare esophageal disease with a wide spectrum of presentations from asymptomatic to debilitating symptoms. There is a strong association of EDS with autoimmune diseases, smoking, and medications, but it can also be idiopathic. Due to the sporadic occurrence of EDS, identification requires a high index of suspicion to avoid frequent misdiagnoses. Herein, we present a case of EDS associated with the long-standing use of oral diclofenac with a favorable outcome after therapy with a proton pump inhibitor (PPI).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881116 | PMC |
| http://dx.doi.org/10.7759/cureus.21647 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Esophagitis dissecans superficialis: an unusual desquamative disorder.
Rev Esp Enferm Dig
January 2025
Aparato Digestivo, Hospital Universitario Infanta Leonor.
We present the case of a 62-year-old woman who, during routine gastroscopy for the study of pyrosis, presented findings compatible with esophagitis dissecans superficialis. This is a rare esophageal desquamation disorder of unknown etiology, which generally has a favorable prognosis and good response to antisecretory treatment.
View Article and Find Full Text PDFAn uncommon cause of dysphagia: esophagitis dissecans superficialis secondary to bullous pemphigoid after vaccination for SARS-CoV-2.
Rev Esp Enferm Dig
November 2024
Aparato Digestivo, Hospital Universitario Torrecárdenas, España.
Esophagitis dissecans superficialis (EDS) is an uncommon condition that is infrequently associated with autoimmune dermatoses. We present the case of a 75-year-old patient who developed EDS secondary to bullous pemphigoid after vaccination against SARS-CoV-2, with typical endoscopic and histological findings.
View Article and Find Full Text PDFApixaban-Induced Esophagitis Dissecans Superficialis-Case Report and Literature Review.
Diseases
October 2024
Gastroenterology and Hepatology Institute, "Saint Spiridon" University Hospital, 700111 Iasi, Romania.
Article Synopsis
- Novel direct oral anticoagulants (DOACs) like apixaban are widely used to treat non-valvular atrial fibrillation, but have been linked to adverse reactions such as esophagitis dissecans superficialis (EDS).
- A case study of a 73-year-old woman revealed that after several weeks on apixaban, she experienced weakness, difficulty swallowing, and gastrointestinal bleeding, leading to a diagnosis of EDS.
- The patient was treated with a proton pump inhibitor and iron supplements, and after recovery, opted for rivaroxaban instead of the initially suggested vitamin K antagonist for her anticoagulation therapy.
Esophagitis Dissecans Superficialis After Thermal Injury.
ACG Case Rep J
July 2024
Division of Gastroenterology, Hepatology, & Nutrition, University of Florida, Gainesville, FL.
Esophagitis dissecans superficialis (EDS) is a rare esophageal condition characterized by sloughing of the esophageal mucosal epithelium, typically associated with a desquamating dermatologic disorder or mucosal irritants. We present a case of a 49-year-old man who presented for thermal burns sustained from an outdoor heater explosion. On body trauma imaging, he was incidentally found to have a midcervical esophageal prominence causing asymptomatic posterior tracheal compression.
View Article and Find Full Text PDFEsophageal desquamation in pediatrics. Esophagitis dissecans superficialis.
An Pediatr (Engl Ed)
June 2024
Servicio de Pediatría, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!